Jiangsu Jibeier Pharm Co., Ltd (SHA: 688566), a Chinese pharmaceutical company, has announced the successful completion of a private placement of 7,446,889 shares at a price of RMB 26.61 per share. The shares will be listed on the Science and Technology Innovation Board (STAR), which is hosted by the Shanghai Stock Exchange (SSE).
The capital raised from the offering, totaling RMB 198.16 million, will be directed towards the construction of a high-end preparation research and development center.
Jibeier Pharm’s business scope encompasses a range of pharmaceutical products aimed at improving white blood cell counts, treating hypertension, enhancing immunity, and more. The company also has a pipeline of drugs under development for conditions such as depression, tumors, gastric diseases, and other therapeutic areas.- Flcube.com
